Skip to content

Exploring the Role of the AIWeLL Health Program on Improving Individual Well-Being

To Evaluate the Effectiveness of a Whole-System Medicine Approach-Based AIWeLL Protocol on Well-Being: A Single-Arm Pre-Post Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089259
Enrollment
171
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

AYUR.AI PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults aged 25 55 years, of any gender 2. Active smartphone users 3. Presence of non-severe, non-life-threatening health concerns related to gastric, metabolic, or women s wellness. 4. Willingness to follow the prescribed Whole-System Medicine (WSM) protocol, including dietary, lifestyle, and mind-body interventions. 5. Ability to provide informed consent and comply with study procedures. 6. No surgical procedures or hospital admissions in the last six months 7. No regular use of prescription medications, over-the-counter drugs, or supplements within 2 weeks prior to screening

Exclusion criteria

Exclusion criteria: 1. Who do not fall under the set cutoffs of Gastric, Metabolic, Women s Wellness Group 2. Diagnosis of severe acute or chronic illness requiring urgent or intensive medical care. 3. Pregnant or breastfeeding women. 4. Use of immunosuppressive therapy or active malignancies. 5. History of major psychiatric disorders that may affect adherence to the intervention. 6. Participation in another clinical study within the past three months. 7. Patients with prediabetes, diabetes. 8. History of substance abuse (e.g., alcohol, tobacco, recreational drugs) 9. Occurrence of myocardial infarction, stroke, or angina within the last 3 months prior to enrolment. 10. Individuals with major diagnosed psychiatric disorders (e.g., depression, schizophrenia).

Design outcomes

Primary

MeasureTime frame
Multi Dimensional Gastrointestinal Symptom Severity Index Waist circumference BMI Womens Health QuestionnaireTimepoint: Before treatment, after treatment

Secondary

MeasureTime frame
Complete Blood Count (CBC), Urine Routine Bilirubin, SGOP, SGPT, LFT, Serum amylase, lipase, lipid profile Gut Microbiota Composition Complete Blood Count (CBC), Urine Routine Fasting & Postprandial (PP) Glucose, HbA1c, Fasting Insulin, Glycated Albumin HDL Cholesterol, LDL Cholesterol, Triglycerides hs-CRP Homocysteine, apolipoproteins Renal Profile, Uric Acid TFT Complete Blood Count (CBC), Urine Routine Prolactin, Progesterone, Estradiol, FSH, LH, DHEA-s, Testosterone, T3, T4, TSH Fasting Glucose, Fasting Insulin, lipid profile Ferritin & Serum Iron Vitamin D (25-Hydroxyvitamin D)Timepoint: Before and after treatment

Countries

India

Contacts

Public ContactDr Devika Deshmukh

Kerala Ayurvedic Clinic

myayurvedaclinic@gmail.com9326169824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026